Evotec surges as Triton said to consider takeover
Evotec surged on Monday as it emerged that private equity firm Triton Partners is considering a takeover bid for the German drug development company after taking a near-10% stake.
Novo Nordisk placed on JPM's Catalyst Watch list into headline data
Investing.com -- Novo Nordisk (CSE: NOVOb) has been placed on JPMorgan’s Catalyst Watch list, signaling heightened anticipation as the company approaches a pivotal moment in its development pipeline.
US minority veterans face unequal access to Ozempic and Wegovy, study finds
(Reuters) - U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk (NYSE: NVO )'s highly in-demand drugs for diabetes and weight loss, according to a review of patient data ...